Stocks are up but so is anxiety about the future. Find out why in the next Axios AM.


NIH announces first human trial for universal flu vaccine

In this image, two gloved hands administer a shot into someone's shoulder.
Photo: Sergei Fadeichev\TASS via Getty Images

Scientists at the National Institutes of Health announced the start of the first in-human trial for a universal influenza vaccine on Wednesday, known as H1ssF_3928.

Driving the news: The creation of a universal vaccine has been prioritized by the National Institute of Allergy and Infectious Diseases (NIAID) in part to protect against a pandemic strain that could kill millions like the 1918 flu pandemic. The H1ssF_3928 clinical trial, which will gradually enroll at least 53 adults, is ongoing at the NIH Clinical Center in Bethesda, Maryland.

Go deeper: Pandemic flu is #1 health security concern, per WH official